Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.10% | 125.14 | 0.0% | $2517.24m | |
| BNGO | BioNano Genomics, Inc. | -11.93% | 8.05 | 0.0% | $1626.30m | |
| GILD | Gilead Sciences, Inc. | 1.37% | 67.99 | 1.0% | $696.88m | |
| AMGN | Amgen, Inc. | 1.65% | 252.36 | 1.3% | $574.64m | |
| CRSP | CRISPR Therapeutics AG | -4.30% | 189.77 | 0.6% | $516.52m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.57% | 542.27 | 2.7% | $477.27m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.61% | 157.74 | 2.0% | $471.04m | |
| NVAX | Novavax, Inc. | -2.31% | 125.05 | 92.9% | $463.88m | |
| ILMN | Illumina, Inc. | 3.42% | 403.54 | 3.5% | $395.72m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.04% | 96.76 | 13.8% | $351.95m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.07% | 236.70 | 1.9% | $351.25m | |
| BIIB | Biogen, Inc. | -1.30% | 270.28 | 1.7% | $328.68m | |
| BNTX | BioNTech SE | -1.40% | 103.23 | 0.0% | $308.28m | |
| OCGN | Ocugen, Inc. | -4.70% | 2.23 | 0.0% | $294.71m | |
| PACB | Pacific Biosciences of California, Inc. | -4.02% | 38.59 | 7.4% | $258.16m |
Company Profile
XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.